News
Low FODMAP Diet and Disordered Eating in IBS

Low FODMAP Diet and Disordered Eating in IBS

A new study published in September has reinforced how, for people with IBS who have been taught the low FODMAP diet, uncontrolled digestive symptoms and psychological distress can be linked to disordered eating behaviours. It can help us think about how patients are...

read more
The Financial Infrastructure Behind Healthcare Innovation

The Financial Infrastructure Behind Healthcare Innovation

Healthcare is changing faster than I have ever seen it change, and the revenue cycle has to keep pace. We are talking about AI, new treatments, new technology, new specialties and entirely new ways of delivering care. All of that is exciting, and much of it has the...

read more
When the Model Is Confident and the Patient Is Not

When the Model Is Confident and the Patient Is Not

It is 2:07 a.m. in the emergency department. The waiting room is thin. The hallway is not. A middle-aged man looks pale. His vitals sit in the green band. A clinical decision support tile on the chart says low risk with a high confidence score. His wife keeps saying...

read more
Weekly News Roundup | 28 September 2026

Weekly News Roundup | 28 September 2026

Life science news 28 September 2026: four US drug approvals, three UK developments and two global R&D deals. The FDA approved Atebrioz, the third treatment for fibrodysplasia ossificans progressiva, and AbbVie’s Parkinson’s drug Juvmo. The MHRA approved...

read more
Surgical Site Infections Can Consume Up to 75 Staff Hours

Surgical Site Infections Can Consume Up to 75 Staff Hours

Surgical site infections can consume up to 75 staff hours and displace three operations, research finds A single surgical site infection (SSI) can consume an estimated 45 to 75 additional hours of healthcare staff time and create downstream demands equivalent to the...

read more
Weekly News Roundup | 07 September 2026

Weekly News Roundup | 07 September 2026

Life science news 7 September 2026: two US approvals, a UK suspension, a Phase 3 failure and four global deals. PharmaEssentia won FDA approval for Besremi in essential thrombocythemia, a label expansion for the interferon therapy. The MHRA suspended Avacopan Vifor...

read more
GLP-1 Indications: The 2026 Regulatory Status Map

GLP-1 Indications: The 2026 Regulatory Status Map

The list of approved GLP-1 indications now reaches well beyond weight loss and glycaemic control. Regulators in three major markets have licensed the class across cardiology, nephrology and hepatology. Other conditions carry positive phase 3 data but no licence at...

read more
Weekly News Roundup | 31 August 2026

Weekly News Roundup | 31 August 2026

Life science news 31 August 2026: three US approvals, two UK device safety alerts and two licensing deals. Revolution Medicines won approval for a broad RAS-targeted pancreatic cancer drug. AstraZeneca and Ionis presented the full data behind a closely watched heart...

read more
Weekly News Roundup | 24 August 2026

Weekly News Roundup | 24 August 2026

Life science news 24 August 2026: the FDA clears Regeneron’s Pasatru for an ultra-rare bone disorder and grants Ultragenyx the first gene therapy for glycogen storage disease type Ia, authorises the first standalone robotic blood-draw device, and the MHRA opens a...

read more
Physical Activity and Dementia: The Evidence Base Is Uneven

Physical Activity and Dementia: The Evidence Base Is Uneven

The link between physical activity and dementia depends on where that activity happens, according to a meta analysis of 74 studies covering more than four million adults. Leisure time exercise was associated with a lower risk of dementia, while activity undertaken at...

read more